Master skills to implement in your practice immediately with continued SLP Master Class. This 4-hour master class will identify factors contributing to polypharmacy during the COVID-19 pandemic. It will describe the risks and long-term effects of polypharmacy and COVID-19 on the respiratory, neurological, cognitive, and gastrointestinal systems involved in dysphagia, and will include discussion of specialized populations such as skilled nursing residents, children and teens, individuals on mechanical ventilation, and individuals with reflux.
Please note: This series is comprised of the following individual courses: 9457, 9466, 9458, and 9490. If you have completed any of these individual courses in the live or video formats, you will NOT be able to earn CEU credit for this course series (9430).
Course created on October 1, 2020
On Demand
Course Type: Video
CEUs/Hours Offered: ASHA/0.4 Intermediate, Professional; IACET/0.4; Kansas LTS-S1370/4.0; SAC/4.0
Learning Outcomes
- After this course, participants will be able to list contributory factors and risks associated with polypharmacy and COVID-10, as they relate to the respiratory system of dysphagia.
- After this course, participants will be able to describe the relationship between COVID-19 and the neurological system of dysphagia, particularly for residents of skilled nursing facilities and those on mechanical ventilation.
- After this course, participants will be able to describe the risks of polypharmacy and COVID-19 associated with dysphagia, speech-language disorders and cognitive decline in children, teens and adults.
- After this course, participants will be able to describe the long-term effects of polypharmacy on the gastrointestinal system in patients recovering from COVID-19, particularly for those with reflux.
Agenda
| 0-60 Minutes | Polypharmacy & the SLP during the COVID-19 Pandemic: Part 1 |
| 60-120 Minutes | Polypharmacy & the SLP during the COVID-19 Pandemic: Part 2 |
| 120-180 Minutes | Polypharmacy & the SLP during the COVID-19 Pandemic: Part 3 |
| 180-240 Minutes | Polypharmacy & the SLP during the COVID-19 Pandemic: Part 4 |
Reviews
1526 ReviewsPresented By
Jeanna Winchester
PhD
Jeanna Winchester, PhD is a clinical cognitive neuroscientist who specializes in neurodegeneration and aging. She is a professor, a published author, and a scientist.
More
Sponsor Disclosure: This Course is presented by SpeechPathology.com, a Continued site.
Content Disclosure: This learning event does not focus exclusively on any specific product or service.
Course participation information
To ensure you are ready to participate, please complete our short Test Drive to prepare your computer to view the course.
Login and logout times will be recorded and documented.
Passing an online exam and completing a course evaluation will be required to earn continuing education credit.
Live Webinars allow presenter and participant interaction. The exam and course evaluation for these courses must be completed within 7 days of the event.
On-demand courses include texts, video and audio recordings of live webinars, and multimedia formats. The exam and course evaluation for on-demand courses must be completed within 30 days of course registration.
To participate in the course, complete the exam and course evaluation, and earn continuing education credit, you must be a SpeechPathology.com member. Participants must complete the entire course; partial credit is not allowed.
SpeechPathology.com is committed to ensuring accessibility to the widest possible audience. We are continually improving the user experience for everyone. If you have questions, requests, or would like to report an accessibility-related issue, please email accessibility@continued.com. We will review your request and respond in a timely manner.
Visit our Contact us page or give us a call if you have questions.
American Speech-Language-Hearing Assn.
Intermediate Level
0.4 ASHA CEUs
International Association for Continuing Education and Training
Continued, LLC, DBA SpeechPathology.com, is accredited by the International Association for Continuing Education and Training (IACET). Continued complies with the ANSI/IACET Standard, which is recognized internationally as a standard of excellence in instructional practices. As a result of this accreditation, Continued is authorized to issue the IACET CEU. continued, LLC, is authorized by IACET to offer 0.4 CEUs for this program.
Kansas Dept for Aging and Disability Services
Approved for 4 continuing education clock hour(s) for Kansas licensed Speech Pathologists by the Kansas Department for Aging and Disability Services. Long-Term Sponsorship number: LTS-S1370.
California Speech-Language Pathology and Audiology Board: SpeechPathology.com is approved by the California Speech-Language Pathology and Audiology Board as a Continuing Professional Development Provider, approval number PDP 268. This course may meet the requirements for 4 hours of continuing education credit for SLPs as required by the California Speech-Language Pathology and Audiology and Hearing Aid Dispensers Board. The responsibility for determining whether or not this specific course counts toward an individual's requirements for license renewal is up to the individual. Please refer to the CA state board rules regarding allowable topics and self-study limits: http://www.speechandhearing.ca.gov/licensees/ce_req.shtml. Live webinars on SpeechPathology.com do not count as self-study courses toward California professional development requirements.
Speech-Language and Audiology Canada
Clinically certified members of Speech-Language and Audiology Canada (SAC) can accumulate continuing education equivalents (CEEs) for their participation with SpeechPathology.com. One hour of coursework equals 1 CEE. All SAC members are encouraged to participate in on-going education.